CIK 0001528172 · Non-accelerated filer<br>Smaller reporting company
ENDONOVO THERAPEUTICS, INC.
Sign in to watch- Ticker
- ENDV
- Exchange
- OTC
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452552528
- Phone
- (800) 489-4774
- Business address
- 6320 CANOGA AVENUE, 15TH FLOOR, WOODLAND HILLS, CA, 91367
- Former names
- Hanover Portfolio Acquisitions, Inc.
- 4 Open-market buy Director bought 100 shares at $0.96 ($96)
- 8-K Event Shareholder rights changed
- 4/A Open-market buy CEO bought 200 shares at an average $2.00 ($400)
- 4/A Open-market buy CEO bought 5,700 shares at an average $0.03 ($163)
- 4 Open-market buy Ceo bought 200 shares at an average $2.00 ($400)
- 4 Open-market buy Ceo bought 5,700 shares at an average $0.00 ($13)
- 8-K Event Shareholder rights changed
- 4 Open-market buy Ceo bought 15,000 shares at an average $0.00 ($46)
- 4 Open-market buy Ceo bought 3,000 shares at an average $0.00 ($11)
- D Other Notice of Sales of Unregistered Securities
- 10-Q Report Quarterly Report
- 4 Open-market buy Ceo bought 2,000 shares at $0.01 ($14)
- NT 10-Q Other NT 10-Q
- DEF 14C Other DEF 14C
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy CEO bought 51,200 shares at an average $0.01 ($269)
- PRE 14C Other PRE 14C
- 4 Open-market buy CEO bought 10,400 shares at an average $0.01 ($107)
- 4 Open-market buy CEO bought 600 shares at an average $0.01 ($6)
- 4 Open-market buy CEO bought 700 shares at an average $0.01 ($5)
Page 4 of 26 · 502 filings